Company: SMNR
Filing Date: 2025-10-21
Form Type: S-1
Source: 0001193125-25-245178
Chunk: 469

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-10-21
Form: S-1
Chunk 469
---
, financing, and mergers and acquisitions opportunities for a period of 12 months from the date of the agreement. In exchange for the services provided and subject to the terms and conditions contained in the consulting services agreement, the Company agreed to issue to 450W42ND MIMA, LLC, the lower of (a) 4.0 million shares or (b) 2% of the outstanding shares, in each case, of common stock of New Semnur following the consummation of the Business Combination. No expense was recorded in connection with such agreement as of June 30, 2025, as the payment of the shares is contingent upon closing of the Business Combination, which occurred subsequent to June 30, 2025, and satisfaction of the terms and conditions contained in the consulting services agreements and no substantial work had been rendered by 450W42ND MIMA, LLC under such agreement as of June 30, 2025. The total value attributable to these shares, if issued, will be determined on the date of issuance with the associated expense to be recognized over the remaining consulting service period determined at that time. On July 22, 2025, the Company entered into an amendment to the foregoing consulting services agreement, pursuant to which the Company agreed to instead issue to 450W42ND MIMA, LLC 3.2 million shares of Semnur Common Stock as finder and advisory retainer fees subject to the satisfaction of the terms and conditions contained in the consulting services agreement, as amended. Consulting Services Agreement with Wise Orient Investments Limited On August 26, 2024, the Company entered into a consulting services agreement with Wise Orient Investments Limited who agreed to perform certain consulting and advisory services related to the Company’s business, financing, and mergers and acquisitions opportunities for a period of 12 months from the date of the agreement. In exchange for the services provided and subject to the terms and conditions contained in the consulting services agreement, the Company agreed to issue to Wise Orient Investments Limited, the lower of (a) 4.0 million shares or (b) 2% of the outstanding shares, in each case, of common stock of New Semnur following the consummation of the Business Combination.No expense was recorded in connection with such agreement as of June 30, 2025, as the payment of the shares is contingent upon closing of the Business F-96

Combination, which occurred subsequent to June 30, 2025, and satisfaction of the terms and conditions